|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net change due to operating activities: | |||||
| Provision (benefit) for credit losses | |||||
| Net change in Loans held for sale | |||||
| Depreciation, amortization, and accretion | |||||
| Deferred income tax expense (benefit) | |||||
| Share-based compensation | |||||
| Net gain on sale of assets | |||||
| Net (increase) decrease in Other assets | |||||
| Net increase (decrease) in Other liabilities | |||||
| Net change due to operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Investment securities: | |||||
| Purchases of debt securities available for sale | |||||
| Proceeds from maturities and paydowns of debt securities available for sale | |||||
| Proceeds from sales of debt securities available for sale | |||||
| Proceeds from maturities and paydowns of debt securities held to maturity | |||||
| Net (increase) decrease in Interest-bearing deposits in banks | |||||
| Acquisitions, net of cash acquired | |||||
| Purchases of loans | |||||
| Sales of loans | |||||
| Net (increase) decrease in Loans and leases | |||||
| Capital expenditures, net | |||||
| Purchases of bank-owned life insurance | |||||
| Other | |||||
| Net change due to investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Net increase (decrease) in Deposits | |||||
| Net increase (decrease) in Short-term borrowed funds | |||||
| Proceeds from issuance of long-term borrowed funds | |||||
| Repayments of long-term borrowed funds | |||||
| Treasury stock purchased | |||||
| Net proceeds from issuance of preferred stock | |||||
| Redemption of preferred stock | |||||
| Dividends paid to common stockholders | |||||
| Dividends paid to preferred stockholders | |||||
| Premium paid to exchange debt | |||||
| Other | |||||
| Net change due to financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Non-cash items: | |||||
| Transfer of loans from loans held for investment to LHFS | |||||
| Transfer of securities from AFS to HTM | |||||
| Loans securitized and transferred to AFS securities | |||||
| Stock issued for Employee Stock Purchase Plan | |||||
| Fair value of assets acquired, excluding cash and cash equivalents | |||||
| Goodwill and other intangible assets | |||||
| Fair value of liabilities assumed | |||||
| Common stock issued | |||||
| Replacement equity awards | |||||
Loading...